The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Szekanecz, Z.,
Szabó, Z.,
Zeher, M.,
Soós, L.,
Dankó, K.,
Horváth, I. F.,
Lakos, G.:
Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population.
Immunol. Res. 56 (2-3), 439-443, 2013.
Besenyei, T.,
Gyetvai, Á.,
Szabó, Z.,
Fekete, A.,
Kapitány, A.,
Szodoray, P.,
Laki, J.,
Soós, L.,
Sipka, S.,
Szegedi, G.,
Lakos, G.,
Szekanecz, Z.:
Associations entre l'épitope partagé d'HLA, les anticorps anti-peptide citrulliné et les facteurs liés au mode de vie chez des patients hongrois atteints de polyarthrite rhumatoïde: données de la premiére cohorte d'Europe centrale et de l'est.
Revue du Rhumatisme. 79 (1), 93-94, 2012.
Besenyei, T.,
Gyetvai, Á.,
Szabó, Z.,
Fekete, A.,
Kapitány, A.,
Szodoray, P.,
Laki, J.,
Soós, L.,
Sipka, S.,
Szegedi, G.,
Lakos, G.,
Szekanecz, Z.:
Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: data from the first Central-Eastern European cohort.
Joint Bone Spine. 78 (6), 652-653, 2011.
Váncsa, A.,
Gergely, L.,
Ponyi, A.,
Lakos, G.,
Németh, J.,
Szodoray, P.,
Dankó, K.:
Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification : retrospective study of 169 patients.
Joint Bone Spine. 77 (2), 125-130, 2010.
Gyetvai, Á.,
Szekanecz, Z.,
Soós, L.,
Szabó, Z.,
Fekete, A.,
Kapitány, A.,
Teodorescu, M.,
Sipka, S.,
Szegedi, G.,
Lakos, G.:
New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.
Rheumatology (Oxford). 49 (1), 25-33, 2010.
Jaskowski, T. D.,
Hill, H. R.,
Russo, K. L.,
Lakos, G.,
Szekanecz, Z.,
Teodorescu, M.:
Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
J. Rheumatol. 37 (8), 1582-1588, 2010.
Papp, M.,
Altorjay, I.,
Lakos, G.,
Tumpek, J.,
Sipka, S.,
Dinya, T.,
Palatka, K.,
Veres, G.,
Udvardy, M.,
Lakatos, P.:
Evaluation of the Combined Application of Ethanol-Fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Clin. Vaccine Immunol. 16 (4), 464-470, 2009.
Gaál, J.,
Lakos, G.,
Szodoray, P.,
Kiss, J.,
Horváth, I.,
Horkay, E.,
Nagy, G.,
Szegedi, A.:
Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study.
Acta Derm. Venereol. 89 (2), 140-144, 2009.
Szántó, S.,
Aleksza, M.,
Mihály, E.,
Lakos, G.,
Szabó, Z.,
Végvári, A.,
Sipka, S.,
Szekanecz, Z.:
Intracytoplasmic cytokine expression and T cell subset distribution in the peripheral blood of patients with ankylosing spondylitis.
J. Rheumatol. 35 (12), 2372-2375, 2008.
Erdős, M.,
Lakos, G.,
Dérfalvy, B.,
Notarangelo, L. D.,
Durandy, A.,
Maródi, L.:
Molecular genetic analysis of Hungarian patients with the hyper-immunoglobulin M syndrome.
Mol. Immunol. 45 (1), 278-282, 2008.
